Model
Edge
Cidara Therapeutics Inc.
CDTX
Filing type
10-Q
Filing date
Nov 6, 2024
Updated
Nov 7, 2024 ยท 2:08 PM
Copy reference
Filing
10-Q
Q3
Exhibits
EX-31.1
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-31.2
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
EX-32.1
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
EX-32.2
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic